Nathan Singh, MD

Referral Type

Not Accepting New Patients

Appointments

Sees Patients For

Aggressive blood cancers, cellular therapies

Hospital Affiliations

  • Barnes-Jewish Hospital

Experience

Board Certifications

  • Internal Medicine
  • Hematology

Academic Title(s)

Associate Professor of Medicine
Division of Oncology
Section of Cellular Therapies

Research Interests

Synthetic immune cells

Publications & Research

View research profile »

Education

Fellowship: Hematology/Oncology

2019 University of Pennsylvania, Philadelphia, PA

Residency: Internal Medicine

2016 University of Pennsylvania, Philadelphia, PA

Medical Degree

2013 University of Pennsylvania, Philadelphia, PA

Master's Degree: Translational Immunology

2013 University of Pennsylvania, Philadelphia, PA

Bachelor's Degree: Spanish Literature

2006 Haverford College, Haverford, PA

Financial Disclosures
  • Phoreus
    • Equity: Yes
    • Reporting Date: 05/01/2024

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Is this your bio page? Request an edit